Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2012, Article ID 132049, 11 pages
http://dx.doi.org/10.1155/2012/132049
Research Article

Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls

1Department of Infectious Diseases, LUMC, P.O. Box 9600, 2300 RC Leiden, The Netherlands
2Leprosy section, Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
3The Laboratory of Cellular Microbiology, Oswaldo Cruz Institute, FIOCRUZ, 21040-360 Rio de Janeiro, RJ, Brazil
4School of Medical Sciences, State University of Rio de Janeiro, 20550-170 Rio de Janeiro, RJ, Brazil

Received 9 August 2011; Accepted 7 October 2011

Academic Editor: John Spencer

Copyright © 2012 Kidist Bobosha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. J. Lockwood and S. Suneetha, “Leprosy: too complex a disease for a simple elimination paradigm,” Bulletin of the World Health Organization, vol. 83, no. 3, pp. 230–235, 2005. View at Google Scholar · View at Scopus
  2. L. C. Rodrigues and D. N. J. Lockwood, “Leprosy now: epidemiology, progress, challenges, and research gaps,” The Lancet Infectious Diseases, vol. 11, no. 6, pp. 464–470, 2011. View at Publisher · View at Google Scholar
  3. D. M. Scollard, L. B. Adams, T. P. Gillis, J. L. Krahenbuhl, R. W. Truman, and D. L. Williams, “The continuing challenges of leprosy,” Clinical Microbiology Reviews, vol. 19, no. 2, pp. 338–381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. “Global leprosy situation, 2010,” Weekly Epidemiological Record, vol. 85, no. 35, pp. 337–348, 2010.
  5. L. Oskam, E. Slim, and S. Bührer-Sékula, “Serology: recent developments, strengths, limitations and prospects: a state of the art overview,” Leprosy Review, vol. 74, no. 3, pp. 196–205, 2003. View at Google Scholar · View at Scopus
  6. J. S. Spencer, H. J. Kim, W. H. Wheat et al., “Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy,” Clinical and Vaccine Immunology, vol. 18, no. 2, pp. 260–267, 2011. View at Publisher · View at Google Scholar
  7. A. Geluk, K. E. van Meijgaarden, K. L. M. C. Franken et al., “Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis,” Infection and Immunity, vol. 70, no. 5, pp. 2544–2548, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Geluk, K. E. van Meijgaarden, K. L. M. C. Franken et al., “Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis,” Scandinavian Journal of Immunology, vol. 59, no. 1, pp. 66–70, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Geluk, M. R. Klein, K. L. M. C. Franken et al., “Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection,” Infection and Immunity, vol. 73, no. 9, pp. 5636–5644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Spencer, H. M. Dockrell, H. J. Kim et al., “Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy,” Journal of Immunology, vol. 175, no. 12, pp. 7930–7938, 2005. View at Google Scholar · View at Scopus
  11. G. Ferrara, M. Losi, R. D'Amico et al., “Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study,” The Lancet, vol. 367, no. 9519, pp. 1328–1334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Geluk, J. van der Ploeg, R. O. B. Teles et al., “Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection,” Clinical and Vaccine Immunology, vol. 15, no. 3, pp. 522–533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Geluk, J. S. Spencer, K. Bobosha et al., “From genome-based in silico predictions to ex vivo verification of leprosy diagnosis,” Clinical and Vaccine Immunology, vol. 16, no. 3, pp. 352–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Geluk and T. H. M. Ottenhoff, “HLA and leprosy in the pre and postgenomic eras,” Human Immunology, vol. 67, no. 6, pp. 439–445, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. T. H. M. Ottenhoff, J. B. A. G. Haanen, A. Geluk et al., “Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy,” Immunological Reviews, no. 121, pp. 171–191, 1991. View at Google Scholar · View at Scopus
  16. T. H. M. Ottenhoff, S. Neuteboom, D. G. Elferink, and R. R. P. de Vries, “Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients,” Journal of Experimental Medicine, vol. 164, no. 6, pp. 1923–1939, 1986. View at Google Scholar · View at Scopus
  17. S. M. Arend, P. Andersen, K. E. van Meijgaarden et al., “Detection of active tuberculosis infection by T cell responses to early- secreted antigenic target 6-kDa protein and culture filtrate protein 10,” Journal of Infectious Diseases, vol. 181, no. 5, pp. 1850–1854, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Arend, A. Geluk, K. E. van Meijgaarden et al., “Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides,” Infection and Immunity, vol. 68, no. 6, pp. 3314–3321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. M. C. Franken, H. S. Hiemstra, K. E. van Meijgaarden et al., “Purification of His-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent,” Protein Expression and Purification, vol. 18, no. 1, pp. 95–99, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Geluk, J. J. V. D. P. V. Schip, K. E. van Meijgaarden et al., “Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays,” Clinical and Vaccine Immunology, vol. 17, no. 6, pp. 993–1004, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. M. Dockrell, S. Brahmbhatt, B. D. Robertson et al., “A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents,” Infection and Immunity, vol. 68, no. 10, pp. 5846–5855, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. R. E. Weir, G. F. Black, H. M. Dockrell et al., “Mycobacterial purified protein derivatives stimulate innate immunity: malawians show enhanced tumor necrosis factor alpha, interleukin-1β (IL-1β), and IL-10 responses compared to those of adolescents in the United Kingdom,” Infection and Immunity, vol. 72, no. 3, pp. 1807–1811, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Wilkinson, P. Patel, M. Llewelyn et al., “Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis,” Journal of Experimental Medicine, vol. 189, no. 12, pp. 1863–1873, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. E. A. Misch, W. R. Berrington, J. C. Vary Jr., and T. R. Hawn, “Leprosy and the human genome,” Microbiology and Molecular Biology Reviews, vol. 74, no. 4, pp. 589–620, 2010. View at Publisher · View at Google Scholar · View at Scopus